Paper 48 - INTRA-ARTICULAR INJECTIONS OF AMB-05X, A POTENT, SELECTIVE, HUMAN MONOCLONAL ANTIBODY AGAINST COLONY STIMULATING FACTOR 1 RECEPTOR FOR THE TREATMENT OF TENOSYNOVIAL GIANT CELL TUMOR

Author(s)

• 

  Michiel van de Sande, MD, PhD (he/him/his)

  Prof
  Leiden University Medical Center, Leiden, Netherlands
  Leiden, Zuid-Holland, Netherlands

  Slides PDF

Co-Author(s)

• 

  Thomas J. Scharschmidt, MD

  Associate Professor
  Ohio State University Wexner Medical Center
  Columbus, Ohio, United States
• OK

  Oleg Kostogryz, MD

  National Academy of Medical Sciences
  Kyiv, Kyyiv, Ukraine
• Kv

  Kirsten van Langevelde, MD

  Leiden University Medical Center
  Leiden, Utrecht, Netherlands
• MC

  Michele Calleja, MD

  Royal National Orthopaedic Hospital NHS Trust
  Stanmore, England, United Kingdom
• 

  Earl Brien, MD

  Director, Orthopedic Oncology Program; Professor, Orthopedic Surgery
  Cedars-Sinai Medical Center
  Los Angeles, California, United States
• KJ

  Kirk Johnson, PhD

  Chief Scientific Officer
  AmMax Biopharma
  Redwood City, California, United States
• 

  Michael Huang, MD

  Chief Medical Officer
  AmMax Biopharma
  Redwood City, California, United States
• 

  Hans Gelderblom, MD, PhD

  Professor medical oncology
  Leiden University Medical Center, Leiden, Netherlands
  Leiden, Zuid-Holland, Netherlands